Advances in DNA/RNA Sequencing and Their Applications in Acute Myeloid Leukemia (AML)

Overview

Journal Int J Mol Sci

Publisher MDPI

Date 2025 Jan 11

PMID 39795930

Authors

Fatimah Ahmed

Jiang Zhong

Affiliations

Soon will be listed here.

Abstract

Acute myeloid leukemia (AML) is an aggressive malignancy that poses significant challenges due to high rates of relapse and resistance to treatment, particularly in older populations. While therapeutic advances have been made, survival outcomes remain suboptimal. The evolution of DNA and RNA sequencing technologies, including whole-genome sequencing (WGS), whole-exome sequencing (WES), and RNA sequencing (RNA-Seq), has significantly enhanced our understanding of AML at the molecular level. These technologies have led to the discovery of driver mutations and transcriptomic alterations critical for improving diagnosis, prognosis, and personalized therapy development. Furthermore, single-cell RNA sequencing (scRNA-Seq) has uncovered rare subpopulations of leukemia stem cells (LSCs) contributing to disease progression and relapse. However, widespread clinical integration of these tools remains limited by costs, data complexity, and ethical challenges. This review explores recent advancements in DNA/RNA sequencing in AML and highlights both the potential and limitations of these techniques in clinical practice.

References

Kerbs P, Vosberg S, Krebs S, Graf A, Blum H, Swoboda A . Fusion gene detection by RNA-sequencing complements diagnostics of acute myeloid leukemia and identifies recurring rearrangements. Haematologica. 2021; 107(1):100-111. PMC: 8719081. DOI: 10.3324/haematol.2021.278436. View

Stetson L, Balasubramanian D, Pereira Ribeiro S, Stefan T, Gupta K, Xu X . Single cell RNA sequencing of AML initiating cells reveals RNA-based evolution during disease progression. Leukemia. 2021; 35(10):2799-2812. PMC: 8807029. DOI: 10.1038/s41375-021-01338-7. View

Satam H, Joshi K, Mangrolia U, Waghoo S, Zaidi G, Rawool S . Next-Generation Sequencing Technology: Current Trends and Advancements. Biology (Basel). 2023; 12(7). PMC: 10376292. DOI: 10.3390/biology12070997. View

Juul-Dam K, Shukla N, Cooper T, Cuglievan B, Heidenreich O, Kolb E . Therapeutic targeting in pediatric acute myeloid leukemia with aberrant HOX/MEIS1 expression. Eur J Med Genet. 2024; 66(12):104869. PMC: 11195042. DOI: 10.1016/j.ejmg.2023.104869. View

Morita K, Wang F, Jahn K, Hu T, Tanaka T, Sasaki Y . Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics. Nat Commun. 2020; 11(1):5327. PMC: 7577981. DOI: 10.1038/s41467-020-19119-8. View

Welch J . Mutation position within evolutionary subclonal architecture in AML. Semin Hematol. 2014; 51(4):273-81. DOI: 10.1053/j.seminhematol.2014.08.004. View

Pan Z, Zhang M, Zhang F, Pan H, Li Y, Shao Y . Single-Cell Transcriptomics Unveils the Dedifferentiation Mechanism of Lung Adenocarcinoma Stem Cells. Int J Mol Sci. 2023; 24(1). PMC: 9820263. DOI: 10.3390/ijms24010482. View

Walter C, Pozzorini C, Reinhardt K, Geffers R, Xu Z, Reinhardt D . Single-cell whole exome and targeted sequencing in NPM1/FLT3 positive pediatric acute myeloid leukemia. Pediatr Blood Cancer. 2017; 65(2). DOI: 10.1002/pbc.26848. View

Smedley D, Smith K, Martin A, Thomas E, McDonagh E, Cipriani V . 100,000 Genomes Pilot on Rare-Disease Diagnosis in Health Care - Preliminary Report. N Engl J Med. 2021; 385(20):1868-1880. PMC: 7613219. DOI: 10.1056/NEJMoa2035790. View

10.

Mazzarella L, Riva L, Luzi L, Ronchini C, Pelicci P . The genomic and epigenomic landscapes of AML. Semin Hematol. 2014; 51(4):259-72. DOI: 10.1053/j.seminhematol.2014.08.007. View

11.

Deepak Shyl E, Malgija B, Iniyan A, Mahendran R, Vincent S . Mining of transcriptome identifies CD109 and LRP12 as possible biomarkers and deregulation mechanism of T cell receptor pathway in Acute Myeloid Leukemia. Heliyon. 2022; 8(10):e11123. PMC: 9589179. DOI: 10.1016/j.heliyon.2022.e11123. View

12.

Logsdon G, Vollger M, Eichler E . Long-read human genome sequencing and its applications. Nat Rev Genet. 2020; 21(10):597-614. PMC: 7877196. DOI: 10.1038/s41576-020-0236-x. View

13.

Brown L, Lonsdale A, Zhu A, Davidson N, Schmidt B, Hawkins A . The application of RNA sequencing for the diagnosis and genomic classification of pediatric acute lymphoblastic leukemia. Blood Adv. 2020; 4(5):930-942. PMC: 7065479. DOI: 10.1182/bloodadvances.2019001008. View

14.

Horton C, Hoang L, Zimmermann H, Young C, Grzybowski J, Durda K . Diagnostic Outcomes of Concurrent DNA and RNA Sequencing in Individuals Undergoing Hereditary Cancer Testing. JAMA Oncol. 2023; 10(2):212-219. PMC: 10625669. DOI: 10.1001/jamaoncol.2023.5586. View

15.

Passaro A, Al Bakir M, Hamilton E, Diehn M, Andre F, Roy-Chowdhuri S . Cancer biomarkers: Emerging trends and clinical implications for personalized treatment. Cell. 2024; 187(7):1617-1635. PMC: 7616034. DOI: 10.1016/j.cell.2024.02.041. View

16.

Pedersen-Bjergaard J, Christiansen D, Desta F, Andersen M . Alternative genetic pathways and cooperating genetic abnormalities in the pathogenesis of therapy-related myelodysplasia and acute myeloid leukemia. Leukemia. 2006; 20(11):1943-9. DOI: 10.1038/sj.leu.2404381. View

17.

Ding S, Chen X, Shen K . Single-cell RNA sequencing in breast cancer: Understanding tumor heterogeneity and paving roads to individualized therapy. Cancer Commun (Lond). 2020; 40(8):329-344. PMC: 7427308. DOI: 10.1002/cac2.12078. View

18.

Malone E, Oliva M, Sabatini P, Stockley T, Siu L . Molecular profiling for precision cancer therapies. Genome Med. 2020; 12(1):8. PMC: 6961404. DOI: 10.1186/s13073-019-0703-1. View

19.

Wang R, Chen C, Jing Y, Qin J, Li Y, Chen G . Characteristics and prognostic significance of genetic mutations in acute myeloid leukemia based on a targeted next-generation sequencing technique. Cancer Med. 2020; 9(22):8457-8467. PMC: 7666719. DOI: 10.1002/cam4.3467. View

20.

Chrystoja C, Diamandis E . Whole genome sequencing as a diagnostic test: challenges and opportunities. Clin Chem. 2013; 60(5):724-33. DOI: 10.1373/clinchem.2013.209213. View